Sign inGet started

Vanhove Geertrui

Insider CIK 1771994 · INSY Director · SRZN Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SRZN Surrozen, Inc./DE A Award2022-12-152022-12-199,578$0.41 $3.9K32,412SEC↗
SRZN Surrozen, Inc./DE A Award deriv2022-10-102022-10-131,760— $01,760SEC↗
SRZN Surrozen, Inc./DE D To issuer deriv2022-10-102022-10-1324,587— $00SEC↗
SRZN Surrozen, Inc./DE D To issuer deriv2022-10-102022-10-1310,427— $00SEC↗
SRZN Surrozen, Inc./DE D To issuer deriv2022-10-102022-10-1326,220— $00SEC↗
SRZN Surrozen, Inc./DE D To issuer deriv2022-10-102022-10-131,760— $00SEC↗
SRZN Surrozen, Inc./DE A Award deriv2022-10-102022-10-1326,220— $026,220SEC↗
SRZN Surrozen, Inc./DE A Award deriv2022-10-102022-10-1310,427— $010,427SEC↗
SRZN Surrozen, Inc./DE A Award deriv2022-10-102022-10-1324,587— $024,587SEC↗
SRZN Surrozen, Inc./DE A Award deriv2022-03-012022-03-03125,000$3.11 $388.8K125,000SEC↗
SRZN Surrozen, Inc./DE A Award deriv2021-08-122021-08-1636,647— $036,647SEC↗
INSY Insys Therapeutics, Inc. A Award deriv2019-03-042019-04-1920,935— $020,935SEC↗
INSY Insys Therapeutics, Inc. A Award deriv2019-03-042019-04-2320,935— $020,935SEC↗
INSY Insys Therapeutics, Inc. A Award2019-03-042019-04-198,083— $014,083SEC↗
INSY Insys Therapeutics, Inc. A Award2019-03-042019-04-238,083— $014,083SEC↗
INSY Insys Therapeutics, Inc. A Award deriv2018-04-022019-04-1924,000— $024,000SEC↗
INSY Insys Therapeutics, Inc. A Award deriv2018-04-022019-04-2324,000— $024,000SEC↗
INSY Insys Therapeutics, Inc. A Award2018-04-022019-04-196,000— $06,000SEC↗
INSY Insys Therapeutics, Inc. A Award2018-04-022019-04-236,000— $06,000SEC↗